JBCHEPHARM Cost Of Revenue vs Depreciation And Amortization Analysis

JBCHEPHARM

1,735 10.35 0.60%

JB Chemicals financial indicator trend analysis is infinitely more than just investigating JB Chemicals Pharmac recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether JB Chemicals Pharmac is a good investment. Please check the relationship between JB Chemicals Cost Of Revenue and its Depreciation And Amortization accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in JB Chemicals Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

Cost Of Revenue vs Depreciation And Amortization

Cost Of Revenue vs Depreciation And Amortization Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of JB Chemicals Pharmac Cost Of Revenue account and Depreciation And Amortization. At this time, the significance of the direction appears to have very strong relationship.

The correlation between JB Chemicals' Cost Of Revenue and Depreciation And Amortization is 0.85. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Depreciation And Amortization in the same time period over historical financial statements of JB Chemicals Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of JB Chemicals' Cost Of Revenue and Depreciation And Amortization is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of JB Chemicals Pharmaceuticals are associated (or correlated) with its Depreciation And Amortization. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Depreciation And Amortization has no effect on the direction of Cost Of Revenue i.e., JB Chemicals' Cost Of Revenue and Depreciation And Amortization go up and down completely randomly.

Correlation Coefficient

0.85

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Cost Of Revenue

Cost of Revenue is found on JB Chemicals Pharmac income statement and represents the costs associated with goods and services JB Chemicals provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Depreciation And Amortization

The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.

Most indicators from JB Chemicals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into JB Chemicals Pharmac current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in JB Chemicals Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

The JB Chemicals' current Selling General Administrative is estimated to increase to about 600 M, while Tax Provision is projected to decrease to under 1.1 B.

	2021	2022	2023	2024 (projected)
Gross Profit	15.6B	27.7B	13.3B	9.7B
Total Revenue	24.2B	31.5B	34.5B	36.2B

Gross Profit Total Revenue

JB Chemicals fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Good Will	Intangible Assets	Current Deferred Revenue
Total Assets		0.77	-0.01	0.91	0.99	0.59	0.71	0.97	0.97	0.2	0.98	-0.22	0.05	0.74	0.66	-0.01	0.61	0.97	0.18	-0.37	0.94	0.74	-0.76	0.56	0.94	-0.31
Short Long Term Debt Total	0.77		-0.22	0.77	0.69	0.21	0.94	0.69	0.67	0.22	0.82	-0.11	-0.09	0.53	0.42	-0.16	0.84	0.65	-0.09	-0.44	0.92	0.46	-0.52	0.25	0.87	-0.32
Other Current Liab	-0.01	-0.22		-0.03	0.01	-0.17	-0.23	0.01	0.02	0.01	-0.11	0.43	0.34	-0.02	0.01	0.34	-0.12	-0.03	-0.2	0.06	-0.07	0.15	-0.04	-0.36	-0.01	0.12
Total Current Liabilities	0.91	0.77	-0.03		0.88	0.43	0.72	0.82	0.9	0.11	0.89	-0.04	0.11	0.59	0.48	0.08	0.43	0.84	0.16	-0.15	0.94	0.62	-0.66	0.37	0.86	-0.24
Total Stockholder Equity	0.99	0.69	0.01	0.88		0.64	0.62	0.98	0.97	0.2	0.96	-0.25	0.05	0.75	0.68	-0.01	0.55	0.98	0.22	-0.35	0.89	0.76	-0.77	0.61	0.9	-0.31
Property Plant And Equipment Net	0.59	0.21	-0.17	0.43	0.64		0.25	0.62	0.59	-0.08	0.58	-0.23	0.06	0.64	0.59	0.09	0.26	0.67	0.42	-0.22	0.41	0.66	-0.28	0.94	0.35	0.19
Net Debt	0.71	0.94	-0.23	0.72	0.62	0.25		0.63	0.62	-0.11	0.76	-0.02	-0.16	0.51	0.38	-0.13	0.8	0.61	-0.02	-0.45	0.87	0.41	-0.47	0.29	0.78	-0.14
Retained Earnings	0.97	0.69	0.01	0.82	0.98	0.62	0.63		0.98	0.18	0.95	-0.33	-0.03	0.81	0.77	-0.08	0.63	0.99	0.22	-0.53	0.87	0.74	-0.84	0.64	0.9	-0.36
Accounts Payable	0.97	0.67	0.02	0.9	0.97	0.59	0.62	0.98		0.13	0.94	-0.27	0.0	0.78	0.72	-0.04	0.5	0.98	0.24	-0.43	0.89	0.71	-0.84	0.59	0.9	-0.36
Cash	0.2	0.22	0.01	0.11	0.2	-0.08	-0.11	0.18	0.13		0.19	-0.25	0.19	0.13	0.15	-0.11	0.22	0.13	-0.2	-0.02	0.17	0.21	-0.07	-0.09	0.28	-0.51
Non Current Assets Total	0.98	0.82	-0.11	0.89	0.96	0.58	0.76	0.95	0.94	0.19		-0.28	-0.14	0.77	0.62	-0.2	0.66	0.94	0.15	-0.4	0.94	0.64	-0.73	0.59	0.96	-0.35
Non Currrent Assets Other	-0.22	-0.11	0.43	-0.04	-0.25	-0.23	-0.02	-0.33	-0.27	-0.25	-0.28		0.39	-0.4	-0.34	0.47	-0.2	-0.29	-0.01	0.4	-0.11	-0.03	0.36	-0.43	-0.22	0.52
Cash And Short Term Investments	0.05	-0.09	0.34	0.11	0.05	0.06	-0.16	-0.03	0.0	0.19	-0.14	0.39		-0.25	0.03	0.95	-0.14	-0.02	-0.14	0.28	0.02	0.44	0.12	-0.16	-0.15	0.21
Net Receivables	0.74	0.53	-0.02	0.59	0.75	0.64	0.51	0.81	0.78	0.13	0.77	-0.4	-0.25		0.79	-0.29	0.6	0.82	0.29	-0.6	0.67	0.7	-0.55	0.71	0.72	-0.2
Common Stock Shares Outstanding	0.66	0.42	0.01	0.48	0.68	0.59	0.38	0.77	0.72	0.15	0.62	-0.34	0.03	0.79		-0.01	0.54	0.77	0.48	-0.71	0.57	0.77	-0.58	0.61	0.58	-0.14
Short Term Investments	-0.01	-0.16	0.34	0.08	-0.01	0.09	-0.13	-0.08	-0.04	-0.11	-0.2	0.47	0.95	-0.29	-0.01		-0.21	-0.06	-0.08	0.29	-0.03	0.38	0.15	-0.13	-0.23	0.37
Non Current Liabilities Total	0.61	0.84	-0.12	0.43	0.55	0.26	0.8	0.63	0.5	0.22	0.66	-0.2	-0.14	0.6	0.54	-0.21		0.55	-0.12	-0.71	0.71	0.5	-0.4	0.33	0.72	-0.21
Inventory	0.97	0.65	-0.03	0.84	0.98	0.67	0.61	0.99	0.98	0.13	0.94	-0.29	-0.02	0.82	0.77	-0.06	0.55		0.33	-0.47	0.86	0.75	-0.82	0.68	0.87	-0.29
Other Current Assets	0.18	-0.09	-0.2	0.16	0.22	0.42	-0.02	0.22	0.24	-0.2	0.15	-0.01	-0.14	0.29	0.48	-0.08	-0.12	0.33		-0.04	0.07	0.27	-0.14	0.41	0.04	0.33
Other Stockholder Equity	-0.37	-0.44	0.06	-0.15	-0.35	-0.22	-0.45	-0.53	-0.43	-0.02	-0.4	0.4	0.28	-0.6	-0.71	0.29	-0.71	-0.47	-0.04		-0.39	-0.31	0.57	-0.39	-0.44	0.25
Total Liab	0.94	0.92	-0.07	0.94	0.89	0.41	0.87	0.87	0.89	0.17	0.94	-0.11	0.02	0.67	0.57	-0.03	0.71	0.86	0.07	-0.39		0.64	-0.69	0.4	0.95	-0.29
Total Current Assets	0.74	0.46	0.15	0.62	0.76	0.66	0.41	0.74	0.71	0.21	0.64	-0.03	0.44	0.7	0.77	0.38	0.5	0.75	0.27	-0.31	0.64		-0.36	0.55	0.59	0.01
Common Stock	-0.76	-0.52	-0.04	-0.66	-0.77	-0.28	-0.47	-0.84	-0.84	-0.07	-0.73	0.36	0.12	-0.55	-0.58	0.15	-0.4	-0.82	-0.14	0.57	-0.69	-0.36		-0.38	-0.73	0.45
Good Will	0.56	0.25	-0.36	0.37	0.61	0.94	0.29	0.64	0.59	-0.09	0.59	-0.43	-0.16	0.71	0.61	-0.13	0.33	0.68	0.41	-0.39	0.4	0.55	-0.38		0.37	0.02
Intangible Assets	0.94	0.87	-0.01	0.86	0.9	0.35	0.78	0.9	0.9	0.28	0.96	-0.22	-0.15	0.72	0.58	-0.23	0.72	0.87	0.04	-0.44	0.95	0.59	-0.73	0.37		-0.46
Current Deferred Revenue	-0.31	-0.32	0.12	-0.24	-0.31	0.19	-0.14	-0.36	-0.36	-0.51	-0.35	0.52	0.21	-0.2	-0.14	0.37	-0.21	-0.29	0.33	0.25	-0.29	0.01	0.45	0.02	-0.46

Click cells to compare fundamentals

JB Chemicals Account Relationship Matchups

JB Chemicals fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	18.1B	22.4B	26.1B	35.5B	39.9B	41.9B
Short Long Term Debt Total	382.2M	449.9M	545.6M	5.7B	3.8B	4.0B
Other Current Liab	911.3M	1.1B	1.1B	236.5M	1.4B	1.0B
Total Current Liabilities	3.1B	3.5B	3.8B	5.5B	8.7B	9.1B
Total Stockholder Equity	14.4B	18.1B	21.3B	24.8B	29.2B	30.7B
Property Plant And Equipment Net	5.8B	5.7B	5.7B	5.8B	6.3B	4.5B
Net Debt	92.1M	163.0M	(19.9M)	5.0B	2.9B	3.0B
Retained Earnings	12.3B	15.8B	18.4B	22.8B	25.1B	26.4B
Accounts Payable	1.7B	1.9B	2.2B	2.4B	3.6B	3.7B
Cash	290.1M	286.9M	565.4M	769.3M	882.2M	531.0M
Non Current Assets Total	7.4B	6.9B	13.3B	20.3B	21.4B	22.5B
Cash And Short Term Investments	3.6B	6.9B	566.5M	2.9B	4.6B	3.3B
Net Receivables	3.6B	3.9B	6.2B	5.8B	7.0B	3.8B
Common Stock Shares Outstanding	159.1M	154.6M	154.7M	156.6M	158.6M	113.5M
Short Term Investments	3.3B	6.6B	1.1M	2.2B	3.7B	2.8B
Liabilities And Stockholders Equity	18.1B	22.4B	26.1B	35.5B	39.9B	41.9B
Non Current Liabilities Total	627.2M	794.1M	850.7M	5.2B	2.0B	1.3B
Inventory	2.7B	3.5B	4.1B	4.3B	5.0B	5.3B
Other Current Assets	4.4B	5.1B	8.1B	2.3B	1.9B	2.6B
Other Stockholder Equity	507.7M	2.1B	2.8B	(807.1M)	2.7B	3.4B
Total Liab	3.8B	4.2B	4.7B	10.7B	10.7B	11.2B
Total Current Assets	10.7B	15.5B	12.7B	15.3B	18.5B	10.3B
Accumulated Other Comprehensive Income	(5.2B)	1.6B	2.2B	2.7B	1.3B	1.3B
Common Stock	167.1M	160.5M	154.6M	154.8M	155.2M	131.5M
Intangible Assets	300.9M	321.1M	6.7B	13.2B	13.9B	14.6B
Current Deferred Revenue	1.5B	1.1B	1.2B	1.2B	129.9M	123.4M
Short Term Debt	344.5M	398.5M	339.4M	1.7B	3.4B	3.6B
Other Liab	648.4M	680.7M	742.7M	644.6M	741.2M	536.5M
Net Tangible Assets	14.0B	13.5B	17.2B	14.1B	16.2B	14.2B
Other Assets	105.3M	133.8M	241.6M	123.8M	142.4M	130.7M
Short Long Term Debt	320.4M	326.4M	263.2M	1.7B	3.3B	3.5B
Property Plant Equipment	5.8B	5.7B	5.7B	5.8B	6.6B	5.8B
Long Term Debt Total	12.3M	51.4M	206.2M	4.0B	4.6B	4.8B
Non Current Liabilities Other	59.7M	49.3M	31.7M	25M	17M	28.0M
Net Invested Capital	14.7B	18.4B	21.6B	30.3B	32.8B	23.2B
Cash And Equivalents	290.1M	33.9M	18.2M	269.1M	309.5M	325.0M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Other Information on Investing in JBCHEPHARM Stock

Balance Sheet is a snapshot of the financial position of JB Chemicals Pharmac at a specified time, usually calculated after every quarter, six months, or one year. JB Chemicals Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of JB Chemicals and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which JBCHEPHARM currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

JBCHEPHARM Cost Of Revenue vs Depreciation And Amortization Analysis

Cost Of Revenue vs Depreciation And Amortization

Cost Of Revenue vs Depreciation And Amortization Correlation Analysis

Correlation Coefficient

Cost Of Revenue

Depreciation And Amortization

JB Chemicals fundamental ratios Correlations

JB Chemicals Account Relationship Matchups

High Positive Relationship

High Negative Relationship

JB Chemicals fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in JBCHEPHARM Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 0.99	Total Assets
Inventory	+ 0.99	Retained Earnings
Non Current Assets Total	+ 0.98	Total Assets
Retained Earnings	+ 0.98	Total Stockholder Equity
Inventory	+ 0.98	Total Stockholder Equity
Accounts Payable	+ 0.98	Retained Earnings

Common Stock	- 0.84	Accounts Payable
Common Stock	- 0.84	Retained Earnings
Common Stock	- 0.82	Inventory
Common Stock	- 0.77	Total Stockholder Equity
Common Stock	- 0.76	Total Assets
Intangible Assets	- 0.73	Common Stock